Literature DB >> 7785258

Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.

O Traub1, R Van Bibber.   

Abstract

Patients with insulin-dependent diabetes mellitus are at high risk for vascular disorders such as hypertension, nephropathy, and retinopathy. The most common cause of morbidity and mortality in patients with insulin-dependent diabetes is vascular disease. Despite ongoing research, the pathogenesis of vascular disease in diabetes remains unclear. In recent years, numerous investigators have examined the role of the endothelium-derived relaxing factor, nitric oxide, in the disease state of hypertension and its complications. We review the role of nitric oxide in the development of diabetes-related vascular disease and discuss findings suggesting that nitric oxide metabolism and vascular responsiveness to nitric oxide are altered in diabetes. Patients with diabetes may benefit from therapy that addresses this pathogenic deficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785258      PMCID: PMC1022795     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  47 in total

1.  Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.

Authors:  B Tesfamariam; M L Brown; R A Cohen
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle.

Authors:  K M Azadzoi; I Saenz de Tejada
Journal:  J Urol       Date:  1991-07       Impact factor: 7.450

4.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Metabolic control and amputations among diabetics in primary health care--a population-based intensified programme governed by patient education.

Authors:  M Falkenberg
Journal:  Scand J Prim Health Care       Date:  1990-03       Impact factor: 2.581

6.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.

Authors:  I Saenz de Tejada; I Goldstein; K Azadzoi; R J Krane; R A Cohen
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

8.  Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta.

Authors:  Y Hattori; H Kawasaki; K Abe; M Kanno
Journal:  Am J Physiol       Date:  1991-10

10.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Authors:  R Bucala; K J Tracey; A Cerami
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  2 in total

1.  Effects of ethanolic extract of Jasminum grandiflorum Linn. flowers on wound healing in diabetic Wistar albino rats.

Authors:  Hiren Hirapara; Vishal Ghori; Ashish Anovadiya; Seema Baxi; Chandrabhanu Tripathi
Journal:  Avicenna J Phytomed       Date:  2017 Sep-Oct

2.  Evaluation of wound healing activity of cow urine ark in diabetic Wistar albino rats.

Authors:  Hiren N Hirapara; Vishal M Ghori; Ashish P Anovadiya; Chandrabhanu R Tripathi
Journal:  J Intercult Ethnopharmacol       Date:  2016-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.